Medicare Enrolled
Dr. Amy Eversole, M.D.
Cardiovascular Disease · Stuart, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eversole from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eversole? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eversole
Dr. Amy Eversole is a cardiovascular disease in Stuart, FL, with 20 years in practice. Based on federal Medicare data, Dr. Eversole performed 17,144 Medicare services across 10,778 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eversole received a total of $6,302 from 38 pharmaceutical and/or device companies across 449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eversole is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $6,302 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,144
Medicare services
Top 2% in FL for cardiovascular disease
10,778
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~857 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,467 | $96 | $225 |
| Electrocardiogram (EKG), 12-lead | 2,161 | $11 | $65 |
| Regadenoson injection (Lexiscan) for heart stress test | 2,116 | $42 | $66 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,577 | $90 | $236 |
| Chronic care management, first 20 min/month | 1,459 | $52 | $130 |
| Office visit, established patient (20-29 min) | 1,069 | $66 | $150 |
| Anticoagulant management of patient taking warfarin | 914 | $9 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 823 | $50 | $325 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 792 | $351 | $1,000 |
| Echocardiogram, transthoracic | 588 | $148 | $575 |
| Hospital follow-up visit, moderate complexity | 507 | $65 | $150 |
| Initial hospital admission, moderate complexity | 309 | $106 | $290 |
| Hospital follow-up visit, low complexity | 296 | $42 | $80 |
| Remote pacemaker/defibrillator monitoring, 90 days | 219 | $17 | $54 |
| Hospital follow-up visit, high complexity | 214 | $96 | $220 |
| Remote pacemaker monitoring, 90 days | 178 | $23 | $66 |
| New patient office visit (45-59 min) | 136 | $122 | $350 |
| Ultrasound of both sides of head and neck blood flow | 118 | $145 | $550 |
| Chronic care management, additional 20 min/month | 110 | $39 | $97 |
| Programming of dual lead pacemaker system | 104 | $58 | $150 |
| Initial hospital admission, high complexity | 101 | $144 | $430 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $26 | $104 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 83 | $20 | $60 |
| EKG interpretation and report | 78 | $6 | $44 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 76 | $16 | $69 |
| Injection, aminophyllin, up to 250 mg | 64 | $2 | $2 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 53 | $21 | $70 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 47 | $174 | $500 |
| Programming of single lead pacemaker system | 47 | $51 | $115 |
| Office visit, established patient, complex (40-54 min) | 46 | $142 | $300 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 41 | $26 | $102 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $51 | $285 |
| New patient office visit (30-44 min) | 39 | $83 | $230 |
| Ultrasound of heart, follow-up | 34 | $20 | $85 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $41 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $19 | $170 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $16 | $121 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $11 | $103 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $41 | $185 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $190 | $595 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 16 | $43 | $150 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $133 | $585 |
| Hospital discharge day management, 30 minutes or less | 13 | $67 | $155 |
| Ultrasound of leg arteries or artery grafts | 11 | $197 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.2% high complexity
24.6% medium
68.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,302
Total received (2018-2024)
Avg $900/year across 7 years
Top 34% in FL for cardiovascular disease
38
Companies
449
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,302 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,500
2023$922
2022$1,191
2021$1,006
2020$472
2019$733
2018$478
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,501
PFIZER INC.
$771
E.R. Squibb & Sons, L.L.C.
$579
Abbott Laboratories
$407
Boehringer Ingelheim Pharmaceuticals, Inc.
$273
SANOFI-AVENTIS U.S. LLC
$264
Medtronic, Inc.
$245
AstraZeneca Pharmaceuticals LP
$244
Novartis Pharmaceuticals Corporation
$235
United Therapeutics Corporation
$202
Amgen Inc.
$201
ATRICURE, INC.
$171
Merck Sharp & Dohme LLC
$159
NOVARTIS PHARMACEUTICALS CORPORATION
$140
Boston Scientific Corporation
$104
Esperion Therapeutics, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$60
Actelion Pharmaceuticals US, Inc.
$58
Allergan Inc.
$53
CVRx, Inc.
$53
Alnylam Pharmaceuticals Inc.
$51
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$41
Bayer Healthcare Pharmaceuticals Inc.
$39
Kestra Medical Technology Services, Inc.
$39
Lexicon Pharmaceuticals, Inc.
$38
Impulse Dynamics (USA) Inc.
$32
Biosense Webster, Inc.
$30
Edwards Lifesciences Corporation
$29
Medtronic Vascular, Inc.
$29
Gilead Sciences, Inc.
$28
Sobi, Inc
$22
iRhythm Technologies, Inc.
$18
AGEPHA Pharma FZ LLC
$18
SCPHARMACEUTICALS INC.
$17
Kowa Pharmaceuticals America, Inc.
$16
Novo Nordisk Inc
$16
Kiniksa Pharmaceuticals, Ltd.
$15
Kiniksa Pharmaceuticals International, plc
$14
Top 3 companies account for 45.3% of total payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AURORA EV-ICD MRI SURESCAN · Adempas · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · Carto 3 · ClosureFast · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · INVOKANA · JARDIANCE · Kerendia · LEQVIO · LODOCO · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · MitraClip System · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · TEGSEDI · TYVASO · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $37 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
55
Per 100K population
34.3
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Eversole is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Eversole experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Eversole performed 2,467 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eversole receive payments from pharmaceutical companies?
Yes. Dr. Eversole received a total of $6,302 from 38 companies across 449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eversole's costs compare to other cardiovascular diseases in Stuart?
Dr. Eversole's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eversole) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Stuart
Browse cardiovascular diseases in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology